Results 311 to 320 of about 2,034,935 (392)

Paediatric Hospitalised Immune Thrombocytopenia in Real-Life Recent Viral Infection Outbreaks: A Retrospective Study. [PDF]

Life (Basel)
Ursu CE, Șerban M, Jinca CM, Boeriu E, Ionita I, Coriu D, Brînză M, Tomuleasa C, Arghirescu TS.   +8 more
europepmc   +1 more source

New‐onset autoimmune disease following SARS‐CoV‐2 infection and mRNA vaccination in Norway: A retrospective cohort study

Journal of Internal Medicine, Volume 299, Issue 2, Page 271-282, February 2026.
Abstract Background Studies suggest an increase in autoimmune diseases following SARS‐CoV‐2 infection and/or COVID‐19‐vaccination. We aimed to describe possible associations in Norway. Methods We used information from the emergency preparedness register for COVID‐19, BeredtC19, for all residents aged 18–64 (N = 3,450,080).
Håkon Bøås, Paz Lopez‐Doriga Ruiz, Jesper Dahl, Hanne L. Gulseth, German Tapia   +4 more
wiley   +1 more source

Partial Splenic Angioembolization for Refractory Chronic Immune Thrombocytopenia: A Case Report. [PDF]

Acta Med Philipp
Yap RDD, Quero-Taggaoa AKH.
europepmc   +1 more source

4-Octyl itaconate ameliorates immune thrombocytopenia by modulating megakaryocyte autophagy and apoptosis

Yu‐Ying Chang, Yinglan Jin, Xi Chen, Xiaomin Zhang, Yaoyao Tian, Xinyu Gao, Xiushuai Dong, Wei Wang   +7 more
openalex   +1 more source

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background/Aims Immune checkpoint inhibitors (ICIs) have transformed advanced HCC treatment. The benefit of sequential immunotherapy after prior ICI failure remains unclear. Given the expanded use of atezolizumab plus bevacizumab (Ate/Bev) over the past 5 years, we explored the real‐world outcomes of nivolumab plus ipilimumab (Nivo/Ipi) in ...
Jung Sun Kim, Jeffrey Wong, San‐Chi Chen, David Tai, Hannah Yang, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Chansik An, Su Jin Jang, Masatoshi Kudo, Ho Yeong Lim, Chan Kim, Thomas Yau, Hong Jae Chon   +15 more
wiley   +1 more source

Splenectomy: still a life-saving treatment in immune thrombocytopenia. [PDF]

Haematologica
Rodeghiero F.
europepmc   +1 more source

The comparative efficacy and safety of BTK and SYK inhibitors in immune thrombocytopenia: Network meta-analysis of clinical trials

Ayesh, Hazem, Raneen Bilal Alshareef, Abadi, Amir, Ghanem, Hamid, Usra Ghanem, Sweity, Raghad, Abdallah, Nora, Abulehia, Ayah, Bael, Peter, khateeb, Shorouq   +9 more
openalex   +1 more source

A pilot study of chemoimmunotherapy in the postconsolidation setting for high‐risk neuroblastoma (ANBL19P1): A report from the Children’s Oncology Group

Cancer, Volume 132, Issue 2, 15 January 2026.
Abstract Background Survival for patients with high‐risk neuroblastoma remains poor despite current‐era multimodality treatment that includes postconsolidation GD2‐directed immunotherapy. Given the promising responses in patients who receive dinutuximab‐based chemoimmunotherapy in the relapsed setting, the Children’s Oncology Group ANBL19P1 study ...
Ami V. Desai, Arlene Naranjo, Brian LaBarre, Lulu Chen, Kelly C. Goldsmith, Meaghan P. Granger, Lisa States, Sean G. Green, Mariel Trunzo, Wendy Fitzgerald, Steven G. DuBois, Rochelle Bagatell, Julie R. Park, Araz Marachelian   +13 more
wiley   +1 more source

Plasma interleukin-12 levels as a potential biomarker of fatigue and quality of life in patients with primary immune thrombocytopenia. [PDF]

Blood Res
Wadhera S, Jain A, Sahni A, Swain RN, Singh C, Jandial A, Aggarwal R, Hans R, Prakash G, Khadwal A, Grover S, Das R, Malhotra P.   +12 more
europepmc   +1 more source

The holistic trial: A comprehensive evaluation of two second-line therapeutic approaches for immune thrombocytopenia (ITP) – a pragmatic randomized controlled trial [PDF]

Eirik Tjønnfjord, Inge Christoffer Olsen, Lamya Garabet, Hoa Tran, Doaa El Demerdash, S. S. Al-Kindy, Geir E. Tjønnfjord, Waleed Ghanima   +7 more
openalex   +1 more source